Vaxart Inc: Well-Capitalized to Execute on Multiple Key Clinical and Regulatory Milestones in Covid-19 and Norovirus Programs
Vaxart公司:資金充足,可爲Covid-19和諾如病毒項目實施多個重要的臨床和監管里程碑。
Vaxart Inc: Well-Capitalized to Execute on Multiple Key Clinical and Regulatory Milestones in Covid-19 and Norovirus Programs
Vaxart公司:資金充足,可爲Covid-19和諾如病毒項目實施多個重要的臨床和監管里程碑。
譯文內容由第三人軟體翻譯。